{"id":5892,"date":"2022-03-17T15:24:30","date_gmt":"2022-03-17T13:24:30","guid":{"rendered":"https:\/\/covid-19-bilgi.de\/?page_id=5892"},"modified":"2022-11-29T15:17:55","modified_gmt":"2022-11-29T13:17:55","slug":"asi-efsaneleri-ve-komplo-teorileri","status":"publish","type":"page","link":"https:\/\/covid-19-bilgi.de\/tr\/asi-efsaneleri-ve-komplo-teorileri\/","title":{"rendered":"Korona A\u015f\u0131 Mitleri"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

A\u015f\u0131ya Kar\u015f\u0131<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t

Ku\u015fkular\u0131n\u0131z m\u0131 var?<\/h1>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

10 En Yayg\u0131n COVID-19 A\u015f\u0131 Mitleri\u00a0<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Korona a\u015f\u0131lar\u0131n\u0131n uygulanmaya ba\u015fland\u0131\u011f\u0131 g\u00fcnden itibaren b\u00fcy\u00fck bir bilgi ihtiyac\u0131 olu\u015fmu\u015ftur. Maalesef COVID-19 a\u015f\u0131lar\u0131yla ilgili yanl\u0131\u015f bilgiler sosyal medyada en \u00e7ok konu\u015fulup, tart\u0131\u015f\u0131lan konular\u0131n ba\u015f\u0131nda gelmektedir. Bu yanl\u0131\u015f bilgi ve komplo teorileri adeta efsanelere yani mitlere d\u00f6n\u00fc\u015ferek insanlar\u0131 tedirgin etmekte ve a\u015f\u0131 olmalar\u0131n\u0131 engellemektedir. Bu nedenle salg\u0131nla m\u00fccadelede g\u00fcvenilir bilgi \u015fartt\u0131r.<\/p>

Bu sayfada a\u015f\u0131 mitleri ve komplo teorileri hakk\u0131ndaki sorular\u0131 yan\u0131tl\u0131yoruz.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
Mit 1: A\u015f\u0131 i\u015fe yaramaz<\/span><\/div>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Antikor seviyesinin d\u00fc\u015fmekte oldu\u011funda a\u015f\u0131n\u0131n faydas\u0131n\u0131n olmad\u0131\u011f\u0131 do\u011fru mu?<\/strong><\/p>

A\u015f\u0131lamadan birka\u00e7 ay sonra \u00fcretilen antikor seviyeleri d\u00fc\u015fse bile, a\u015f\u0131lama ile koruyucu bir ba\u011f\u0131\u015f\u0131kl\u0131k tepkisi sa\u011flanabilir. \u00c7\u00fcnk\u00fc a\u015f\u0131 ile antikorlara ek olarak, korona bula\u015fm\u0131\u015f h\u00fccreleri tan\u0131yabilen ve yok edebilen ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleri de e\u011fitiliyor.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Mit 2: Korona a\u015f\u0131s\u0131 k\u0131s\u0131rl\u0131\u011fa neden oluyor<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Korona a\u015f\u0131s\u0131n\u0131n kad\u0131nlarda k\u0131s\u0131rl\u0131\u011fa neden olabilece\u011fi do\u011fru mu?<\/strong><\/p>

\u0130nternette dola\u015fan yanl\u0131\u015f bilgiler nedeniyle, korona a\u015f\u0131s\u0131n\u0131n k\u0131s\u0131rl\u0131\u011fa yol a\u00e7t\u0131\u011f\u0131 veya d\u00fc\u015f\u00fck riskini art\u0131rd\u0131\u011f\u0131 endi\u015feleri zaman zaman dile getiriliyor. \u015eimdiye kadar yap\u0131lan ara\u015ft\u0131rmalar, bunun m\u00fcmk\u00fcn olmad\u0131\u011f\u0131 sonucuna varm\u0131\u015ft\u0131r.<\/p>

Olas\u0131 yan etkiler ve a\u015f\u0131lara kar\u015f\u0131 do\u011frudan tepkiler hakk\u0131nda ba\u015fka \u015f\u00fcpheleriniz veya korkular\u0131n\u0131z varsa, doktorunuzla konu\u015fman\u0131z veya Federal Sa\u011fl\u0131k E\u011fitimi Merkezi taraf\u0131ndan sa\u011flanan bilgi hizmeti olan infektionsschutz.de’den daha fazla bilgi alman\u0131z en iyisidir. Paul Ehrlich Enstit\u00fcs\u00fc web sitesinde de uzman bilgileri bulabilirsiniz. Enstit\u00fc, Almanya’da yan etkilerin ve a\u015f\u0131 reaksiyonlar\u0131n\u0131n kay\u0131t alt\u0131na al\u0131nd\u0131\u011f\u0131 merkezi ofistir.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Mit 3: Covid-19 a\u015f\u0131lar\u0131 insan DNA’s\u0131na m\u00fcdahale ediyor<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

mRNA a\u015f\u0131lar\u0131n\u0131n genoma entegrasyon riski nedir?<\/strong><\/p>

mRNA’n\u0131n insan genomuna entegrasyonunun g\u00f6r\u00fclebilir bir riski yoktur. \u0130nsanlarda genom, h\u00fccre \u00e7ekirde\u011finde bulunan DNA formundad\u0131r. RNA’n\u0131n DNA’ya entegrasyonu, di\u011fer sebeplerin yan\u0131 s\u0131ra, farkl\u0131 kimyasal yap\u0131lar\u0131 nedeniyle m\u00fcmk\u00fcn de\u011fildir. Ayr\u0131ca a\u015f\u0131lamadan sonra v\u00fccut h\u00fccreleri taraf\u0131ndan al\u0131nan mRNA’n\u0131n DNA’ya kopyaland\u0131\u011f\u0131na dair hi\u00e7bir kan\u0131t yoktur.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Mit 4: A\u015f\u0131larda \u00a0mikro\u00e7ipler var<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

A\u015f\u0131lar\u0131n mikro\u00e7ip i\u00e7erdi\u011fi do\u011fru mu?<\/strong><\/p>

Bu t\u00fcr varsay\u0131mlar, ger\u00e7ekler de\u011fil, komplo teorileridir. Bu iddia do\u011fru de\u011fil. COVID-19 a\u015f\u0131lar\u0131 \u00fczerine ara\u015ft\u0131rmalar ba\u011f\u0131ms\u0131z bilim adamlar\u0131 taraf\u0131ndan y\u00fcr\u00fct\u00fclmektedir. Ama\u00e7lar\u0131, COVID-19’a kar\u015f\u0131 g\u00fcvenli ve etkili bir koruyucu a\u015f\u0131 geli\u015ftirmektir.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Mit 5: Korona a\u015f\u0131s\u0131 kanser gibi hastal\u0131klara neden oluyor<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Bunun i\u00e7in bir kan\u0131t yok.<\/strong> A\u015f\u0131y\u0131 ara\u015ft\u0131rmak i\u00e7in yap\u0131lan \u00e7al\u0131\u015fmalarda b\u00f6yle bir ba\u011flant\u0131 kurulamad\u0131. Bir a\u015f\u0131, ancak yeterli say\u0131da insan \u00fczerinde test edilmi\u015fse ve etkisinin, ortaya \u00e7\u0131kan yan etkilerden a\u00e7\u0131k\u00e7a daha a\u011f\u0131r bast\u0131\u011f\u0131 do\u011frulanm\u0131\u015fsa onaylan\u0131r. Onaydan sonra bile, klinik ara\u015ft\u0131rmalarda ve di\u011fer \u00e7al\u0131\u015fmalarda pozitif fayda-risk profili s\u00fcrekli olarak kontrol edilir.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Almanya\u2019n\u0131n her yerinden<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t

0800 0000 837<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

No\u2019lu \u00fccretsiz \u00a0T\u00fcrk\u00e7e Dan\u0131\u015fma Hatt\u0131ndan ku\u015fku ve korkular\u0131n\u0131z ile ilgili cevaplar\u0131 ve bilgileri alabilirsiniz.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Mit 6: Ara\u015ft\u0131rmaya kat\u0131lan denekler y\u00fcz felci oldu<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Ara\u015ft\u0131rmaya kat\u0131lan deneklerin y\u00fcz felci ge\u00e7irdi\u011fi do\u011fru mu?<\/strong><\/p>

BioNTech\/Pfizer’den Comirnaty\u00ae’yi test ederken, teste kat\u0131lan denekler zaman zaman fel\u00e7 belirtileri bildirdiler. Y\u00fcz felci (Fazialisparesen )hem a\u015f\u0131lanan grupta hem de plasebo grubunda meydana geldi ve bu nedenle a\u015f\u0131ya nedensel olarak ba\u011flanamaz. A\u015f\u0131 milyonlarca kez kullan\u0131ld\u0131ktan sonra, korona a\u015f\u0131s\u0131 sonras\u0131 y\u00fcz felcine ili\u015fkin ulusal izleme sistemlerinde a\u015f\u0131 g\u00fcvenli\u011fine ili\u015fkin herhangi bir sinyal yoktur.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Mit 7: Denekler bilimsel ara\u015ft\u0131rmalarda \u00f6ld\u00fc<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Deneklerin ara\u015ft\u0131rmalarda \u00f6ld\u00fc\u011f\u00fc do\u011fru mu?<\/strong><\/p>

\u00c7ok say\u0131da hasta ve ya\u015fl\u0131lar\u0131n dahil edildi\u011fi ve daha uzun \u00e7al\u0131\u015fma s\u00fcreleri ile yap\u0131lan klinik \u00e7al\u0131\u015fmalarda, hastalar\u0131n \u00e7al\u0131\u015fma s\u0131ras\u0131nda \u00f6lmesi olas\u0131d\u0131r. Ancak bu, a\u015f\u0131 ile bir ba\u011flant\u0131 oldu\u011fu anlam\u0131na gelmez.<\/p>

Olu\u015fan her yan etki kaydedilir ve her \u00f6l\u00fcm, ba\u011f\u0131ms\u0131z bir kontrol paneli taraf\u0131ndan a\u015f\u0131 ile olas\u0131 bir ba\u011flant\u0131 i\u00e7in dikkatlice incelenir. Paul-Ehrlich-Institut, COVID-19 a\u015f\u0131lar\u0131na ili\u015fkin g\u00fcvenlik raporlar\u0131n\u0131 s\u00fcrekli olarak g\u00fcncellemektedir.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Mit 8: Yayg\u0131nl\u0131k (Prevalans) hatas\u0131<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Prevalans: Epidemiyoloji ve t\u0131bbi istatistiklerde Yayg\u0131nl\u0131k (Prevalans), \u00f6rne\u011fin hastal\u0131k s\u0131kl\u0131\u011f\u0131 i\u00e7in \u00f6nemli bir rakamd\u0131r.<\/strong><\/p>

Bir yayg\u0131nl\u0131k (Prevalans) hatas\u0131 fenomenini, hastal\u0131\u011fa yakalanma s\u0131kl\u0131\u011f\u0131 dikkate al\u0131nmamas\u0131 (\u00f6re\u011fin a\u015f\u0131lama oran\u0131) nedeniyle, \u015fartlara ba\u011fl\u0131 bir olas\u0131l\u0131k veya riskinin (\u00f6re\u011fin COVID 19’a yakalanma riski) yanl\u0131\u015f de\u011ferlendirilmesini tan\u0131mlar.<\/p>

Daha iyi anla\u015f\u0131lmas\u0131 i\u00e7in bir \u00f6rnek:\u00a0<\/strong>100 ki\u015fiden 99’u a\u015f\u0131l\u0131, 1’i a\u015f\u0131s\u0131z. Bu 100 ki\u015fiden 2’si COVID-19 hastal\u0131\u011f\u0131 nedeniyle hastaneye geliyor. Hastalardan biri a\u015f\u0131l\u0131, di\u011feri a\u015f\u0131s\u0131z. Bu durumda a\u015f\u0131lananlar\u0131n y\u00fczde 50’sinin hastanede oldu\u011fu varsay\u0131l\u0131rsa,\u00a0yayg\u0131nl\u0131k hatas\u0131 yap\u0131lm\u0131\u015f olur.\u00a0<\/span>\u00c7\u00fcnk\u00fc hastanede kalma olas\u0131l\u0131\u011f\u0131 hesaplan\u0131rken a\u015f\u0131lanma oran\u0131 da hesaba kat\u0131lmal\u0131d\u0131r, yani 100 ki\u015fiden ka\u00e7\u0131n\u0131n a\u015f\u0131l\u0131, ka\u00e7\u0131n\u0131n a\u015f\u0131s\u0131z oldu\u011fu.\u00a0A\u015f\u0131 oran\u0131 dikkate al\u0131n\u0131rsa, a\u015f\u0131s\u0131zlar\u0131n y\u00fczde 100’\u00fc hastanede, a\u015f\u0131l\u0131lar\u0131n ise sadece y\u00fczde 1,01’i hastanede oldu\u011fu ortaya \u00e7\u0131k\u0131yor.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
Mit 9: A\u015f\u0131lar sadece sa\u011fl\u0131kl\u0131 insanlar \u00fczerinde denendi<\/span><\/div>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

A\u015f\u0131lar\u0131n sadece sa\u011fl\u0131kl\u0131 insanlar \u00fczerinde denendi\u011fi do\u011fru mu?<\/strong><\/p>

Bu do\u011fru de\u011fil<\/strong>. Daha \u00f6nce belirli hastal\u0131klar\u0131 olan veya a\u015f\u0131r\u0131 kilolu olan ya\u015fl\u0131lar ve y\u00fcksek riskli hastalar da bu klinik ara\u015ft\u0131rman\u0131n 3. faz\u0131na dahil edildi. Ara\u015ft\u0131rmaya katilim i\u00e7in gerekli olan kat\u0131l\u0131mc\u0131lar\u0131n istikrarl\u0131 bir sa\u011fl\u0131k durumuydu. \u00d6rne\u011fin, yaln\u0131zca ba\u011f\u0131\u015f\u0131kl\u0131k yetmezli\u011fi ve kanama bozukluklar\u0131 olan ki\u015filer ara\u015ft\u0131rma d\u0131\u015f\u0131 b\u0131rak\u0131ld\u0131.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Mit 10: Korona a\u015f\u0131s\u0131 romatizmal hastal\u0131\u011f\u0131 olan ki\u015filer i\u00e7in bir tehlike<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t

Korona a\u015f\u0131s\u0131n\u0131n romatizmal hastal\u0131\u011f\u0131 olan ki\u015filer i\u00e7in potansiyel tehlikeli olabilece\u011fi do\u011fru mu?<\/strong><\/p>

Hay\u0131r, bu do\u011fru de\u011fil.<\/strong> Alman Romatoloji Derne\u011fi (DGRh) 6 Nisan 2021 tarihli tavsiyesi \u015f\u00f6yle: “A\u015f\u0131 bile\u015fenlerine kar\u015f\u0131 bilinen alerjiler d\u0131\u015f\u0131nda, COVID-19 a\u015f\u0131s\u0131 i\u00e7in herhangi bir kontrendikasyon yoktur. Bu ayn\u0131 zamanda inflamatuar romatizmal hastal\u0131klar\u0131 olan hastalar ve ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 bask\u0131lay\u0131c\u0131\/ba\u011f\u0131\u015f\u0131kl\u0131k d\u00fczenleyici tedavisinde olan hastalar i\u00e7in de ge\u00e7erlidir.” Ve devam ediyor: “\u015eu anda onaylanan SARS-CoV-2’ye kar\u015f\u0131 t\u00fcm a\u015f\u0131lar canl\u0131 a\u015f\u0131 de\u011fildir. Bu “canl\u0131 olmayan a\u015f\u0131lar”, inflamatuar romatizmal hastal\u0131klar\u0131 olan hastalarda ve imm\u00fcnosupresif\/ba\u011f\u0131\u015f\u0131kl\u0131k mod\u00fclasyonu olan hastalarda k\u0131s\u0131tlama olmaks\u0131z\u0131n kullan\u0131labilir.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

G\u00fcncellik: 04.2022,<\/em> Kaynak: Bundesministerium f\u00fcr Gesundheit<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

A\u015f\u0131ya Kar\u015f\u0131 Ku\u015fkular\u0131n\u0131z m\u0131 var? 10 En Yayg\u0131n COVID-19 A\u015f\u0131 Mitleri\u00a0 Korona a\u015f\u0131lar\u0131n\u0131n uygulanmaya ba\u015fland\u0131\u011f\u0131 g\u00fcnden itibaren b\u00fcy\u00fck bir bilgi ihtiyac\u0131 olu\u015fmu\u015ftur. Maalesef COVID-19 a\u015f\u0131lar\u0131yla ilgili yanl\u0131\u015f bilgiler sosyal medyada en \u00e7ok konu\u015fulup, tart\u0131\u015f\u0131lan konular\u0131n ba\u015f\u0131nda gelmektedir. Bu yanl\u0131\u015f bilgi ve komplo teorileri adeta efsanelere yani mitlere d\u00f6n\u00fc\u015ferek insanlar\u0131 tedirgin etmekte ve a\u015f\u0131 olmalar\u0131n\u0131 engellemektedir. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/covid-19-bilgi.de\/tr\/wp-json\/wp\/v2\/pages\/5892"}],"collection":[{"href":"https:\/\/covid-19-bilgi.de\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/covid-19-bilgi.de\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/covid-19-bilgi.de\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/covid-19-bilgi.de\/tr\/wp-json\/wp\/v2\/comments?post=5892"}],"version-history":[{"count":70,"href":"https:\/\/covid-19-bilgi.de\/tr\/wp-json\/wp\/v2\/pages\/5892\/revisions"}],"predecessor-version":[{"id":8384,"href":"https:\/\/covid-19-bilgi.de\/tr\/wp-json\/wp\/v2\/pages\/5892\/revisions\/8384"}],"wp:attachment":[{"href":"https:\/\/covid-19-bilgi.de\/tr\/wp-json\/wp\/v2\/media?parent=5892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}